11 experts predict what's in store for FemTech and women's health in 2025
Key insights from the people closest to innovation in women's health
As we step into 2025, the landscape of women’s health innovation and FemTech is more dynamic than ever before. Where it was once considered a niche segment (sigh!), there’s palpable momentum as well as significant investment flowing into the sector.
The global FemTech market is now forecast to reach over $117 billion by 2029. And while still much more investment is needed into both innovation and research to close the gender health gap, there is a surge of progress.
For this article, we asked 11 leading industry experts to share their key insights and predictions for women’s health innovation and FemTech in 2025.
Hear about the the rise of personalization in FemTech, new trends in ‘intimate longevity’, through to likely consolidation in the sector and why innovation in voice AI and facial analysis will cause ‘devastation’ for at-home women’s health tests. These varied trends highlight what’s next according to the people who are closest to the innovation as it happens. They also underline the real potential of FemTech — both from an investment perspective and for improving lives worldwide.
Read on to find out more from our experts:
1. Hannah Samano, CEO at Unfabled.
“2025 is set to bring exciting growth opportunities in femtech, particularly in personalisation, preventative health, and community-driven care. Consumers are demanding tailored solutions, and leveraging data to deliver personalisation – whether in menstrual health, menopause, or fertility – will be a key driver of innovation. Advances in AI are rapidly accelerating this shift, enabling more accurate insights and building new datasets that help us uncover and address women’s unmet health needs in ways we’ve never been able to before.
“Preventative health and longevity will also be critical growth areas, with supplements, wearables, and diagnostics empowering people to take control of their health earlier and make informed decisions for their future wellbeing.
“Finally, community-driven platforms that combine trusted expertise with peer support will continue to thrive. As people seek relatable, stigma-free spaces for advice, education, and shared experiences, brands that can foster these connections while offering clinically backed solutions will stand out.
2. Dr Brittany Barreto, Author of Unlocking Women’s Health, FemTech and the Quest for Gender Equity
“My biggest prediction is that AI will make major strides and disrupt many existing technologies in femtech. The best and, unfortunately, most devastating innovation will be voice AI and facial analysis, which will predict hormone levels and, therefore, health.
“This will revolutionize female awareness of their bodies. Verbally repeating a short, simple catchphrase and a scan of the face each morning with their phone will let the user know if they are ovulating, about to start their period, should expect a migraine, may feel lower energy than normal, or will have a hot flash. This will inevitably be widely available within the next five years, but I predict it will make its first appearance in 2025.
“The reason it's devastating is that every at-home urine, saliva, respiratory, or blood test for hormones (including fertility, hormone conditions, or perimenopause) will become obsolete. I suggest that these companies try to use the data they already have to create their AI algorithms with voice and facial biomarkers immediately. And to sell their at-home tests to larger buyers while the market still is not privy to what the future looks like - tech-based biometric analysis.”
3. Navneet Kaur, Founder of FemTech India
“India has demographic power; with one of the world’s largest populations of women, it presents a massive growth opportunity for FemTech. Increasing smartphone penetration, digital health adoption, and a growing focus on women’s wellness are setting the stage for explosive demand in this market. The combination of innovation, investment, and consumer demand makes FemTech one of the most exciting spaces to watch in healthcare.
“More broadly, FemTech’s global growth trajectory is nothing short of impressive. By 2025, this industry is expected to hit $50 billion, doubling from $20 billion in 2020.
“Growing technologies in FemTech include AI-powered fertility trackers, smart breast pumps and pelvic health wearables.
“The combination of innovation, investment, and consumer demand makes FemTech one of the most exciting spaces to watch in healthcare.”
4. Delphine Moulu, Cofounder & Managing Director at Femtech France
“France has a significant potential to continue the femtech revolution given the actual political and economical context in the world. France offers a political landscape that is pro women’s rights, one of the best lifescience R&D environments, and a particularly dynamic femtech startup ecosystem.
“However, femtech start-ups encounter difficulties accessing financing.There's still a huge need of funding for European early stage femtech companies. Additionally, businesses led by majority women face significant obstacles, particularly due to persistent biases in the venture capital industry. These gender biases particularly affect companies working on topics related to women's intimate health.
“New investments vehicles will emerge such as the Alliance for Financing FemTech* that we, Femtech France, will launch in early 2025. We have an ambitious objective: to mobilize 200 million euros in public and private financing by 2026. This will be a reflexion and action club with investment experts (investors, insurers, wealth managers) who want to accelerate the funding of French femtech companies.”
*If you are an investor or public institution and are interested in joining the Alliance please contact FemTech France through its website here.
5. Aileen Norton, Founder, Find My Femtech
“A greater emphasis on personalized treatments for endometriosis, PCOS, PMDD, and period-related symptoms will start to replace the outdated, trial-and-error approach of relying on oral contraceptive pills as a one-size-fits-all solution.
“Expect to see enhanced privacy protections for period-tracking apps and stricter clinical research protocols to safeguard reproductive health data, addressing concerns over the collection and storage of menstruation and pregnancy information, particularly in post-Roe America.
“AI-driven tools will enable earlier detection of genetically linked conditions and provide accurate, accessible information through chatbots to combat online misinformation regarding women’s health.
“There will be more women-led investment initiatives and strategic consulting for investors and startups addressing the stigma and discomfort around femtech topics.
“Updates to medical education will prioritize underrepresented topics like menopause, fertility, contraception, and PCOS, addressing long-standing gaps in internal medicine training.”
6. Valerie Evans, Investor at Five Seasons VC
“The healthcare industry is increasingly leveraging technology to bridge longstanding gaps in women's health research. With diagnostic tools and health monitoring devices beginning to specifically address women’s health concerns — like smart rings now equipped with fertility tracking capabilities — technology is evolving to also meet women's health needs. AI is also playing a role in accelerating the usefulness of these tools.
“Companies leveraging AI capabilities can play a pivotal role in addressing the research funding disparity for women's health by enhancing data collection. With more data will come faster development of diagnostic technologies and higher accuracy rates, enabling women to recognize and address symptoms earlier, often bypassing the need to rely solely on physicians.
“As women seek alternatives to traditional doctor visits, the market for consumer-focused healthcare solutions is expanding rapidly. These companies can not only provide tailored solutions but also assist in creating new solutions for women’s needs that are not yet addressed by traditional pharmaceutical routes. With over 80% of women reporting instances where they felt they were not listened to by healthcare professionals, women are searching for solutions on their own and becoming much more knowledgeable about the products that are available and OTC solutions. While there have been some OTC products available for women’s health conditions, there are not many that are truly innovative and efficacious. For example, Midol is essentially repackaged acetaminophen but marketed for period pain and marked up with the pink tax. We have seen challenger brands enter this space in the last decade, but we expect more to do so in 2025, especially ones focused on science-backed, efficacious formulas that may not be able to cure conditions but can help alleviate the symptoms.”
7. Dr Kerry Aston, CMO, Nexus
“In 2025, microbiome science will take centre stage in advancing women’s health, particularly for conditions like endometriosis and autoimmune diseases.
“Emerging technologies will leverage microbiome analysis to provide non-invasive diagnostics, uncovering unique microbial imbalances linked to these conditions. This could revolutionise early detection and offer personalised treatment pathways targeting inflammation, immune modulation, and hormonal balance through microbiome-based therapies.
“For endometriosis, a condition often underdiagnosed and poorly managed, microbiome science offers hope for novel interventions that address systemic inflammation and pain at their root. Similarly, autoimmune diseases, which disproportionately affect women, could see breakthroughs in symptom management and long-term outcomes using probiotic-based treatments and gut-focused therapies informed by individual microbial profiles.”
8. Dr Frances Conti-Ramsden, Obstetrics & Gynaecology Registrar/MRC PhD candidate/CMO MEGI Health
“The healthcare industry is finally waking up to its blind spot: women's bodies, experiences, and data have been systematically overlooked. But some of 2024's breakthrough moments – from Daye's revolutionary tampon technology making Time's top innovations to the landmark inclusion of female-specific factors in QRISK cardiovascular assessments – signal a seismic shift.
“As we look to 2025, expect a surge in technologies that don't just solve individual problems, but tackle systemic ones too. These smart solutions will deliver personalised care while simultaneously gathering crucial data about women's health, killing two birds with one stone. Think menstrual products that track hormone patterns, fertility monitors that contribute to large-scale reproductive health research, or wearables that finally map how medications affect women differently than men. The future of FemTech isn't just about building better products – it's about building a better understanding of half the world's population.”
9. James Stables, founder, PULSE by Wareable
“2024 was a very busy year, with tons of innovation. I'm expecting that to continue in 2025 – but I think the bigger theme will be more of those 2024 ideas coming to market.
“[In the wearables space in particular] an example would be Peri, which is set to launch the US in 2025. That felt quite an early stage start up when I spoke to the founders at CES 2024, so it shows how quickly things can move. I feel that despite the challenges faced by FemTech, there is an appetite among investors and decisions makers, fuelled at least in part by Oura's success. I'm already getting press releases about continuous hormone tech for CES 2025, so I expect this too be an on-going story.”
10. Rachel Braun Scherl, Managing Partner & Co-Founder, SPARK Solutions for Growth
“2025 will be the year that we finally see some of the extraordinary changes in women’s health that the ecosystem has been building to, working toward and waiting for.
“We will see significant consolidation across the consumer companies in women’s sexual and reproductive health. Winners in this space will communicate compelling messaging and meaningful support for claims and outcomes. Many of the supplement companies will have their feet to the fire to support the claims they are currently making.
Companies focused on hormonal health will dominate conversations as increased understanding of hormones’ impact on all life stages and many conditions reaches a crescendo.”
11. Samantha Marshall, Head of Brand, Smile Makers
“2025 will see an increased focus on intimate longevity and preventative care.
“The growing focus on intimate health marks a shift toward body literacy and preventative wellness. This trend centers on “future-proofing pleasure” by addressing pelvic floor health, hormone balance, and sexual function across all life stages, such as menopause, motherhood, and post-surgery. It encourages proactive engagement with health, empowering individuals to take control before challenges arise.
“Modern sexual wellness embraces a holistic approach, recognizing the connection between physical, mental, and emotional well-being. Longevity-focused solutions—such as pelvic floor exercisers, hormone-supportive supplements, and pH-balancing care—are becoming daily considerations. Helping to prioritize pleasure through good intimate health is a lifetime right.”
Conclusion
The women’s health innovation and FemTech space is arguably still in its infancy with so much that is ripe for development and progress. While the speed of that progress often feels frustratingly slow and there remains a gap for much more investment relative to need, there are clear signs of momentum.
2025 will be a year that women’s health moves further centre stage in the public awareness, driving consumer demand and applying much-need pressure on meeting that demand too.